{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T01:41:41Z","timestamp":1775180501432,"version":"3.50.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:p>Management of heavy menstrual bleeding (HMB) in a woman with a history of thrombosis, or who is otherwise at high risk of thrombosis, or who takes medications for anticoagulation can present a challenge to health care providers. The goal of treating HMB is to reduce menstrual blood loss. First-line therapy is typically hormonal, and hormonal therapy can be contraindicated in women with a history of thrombosis unless they are on anticoagulation. As 70% of women on anticoagulation experience HMB, successful management of HMB may involve a modification in the anticoagulation or antiplatelet regimen, hormonal therapy tailored to the patient\u2019s situation, and\/or surgical therapy.<\/jats:p>","DOI":"10.1097\/grf.0000000000000372","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T03:09:28Z","timestamp":1522292968000},"page":"250-259","source":"Crossref","is-referenced-by-count":8,"title":["Managing Heavy Menstrual Bleeding in Women at Risk of Thrombosis"],"prefix":"10.1097","volume":"61","author":[{"given":"ANDREW","family":"RIVARA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANDRA H.","family":"JAMES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230911","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.contraception.2010.12.011","article-title":"Menstrual problems and contraception in women of reproductive age receiving oral anticoagulation","volume":"84","author":"Huq","year":"2011","journal-title":"Contraception"},{"key":"R2-20230911","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11239-006-0003-7","article-title":"Menorrhagia and minor bleeding symptoms in women on oral anticoagulation","volume":"24","author":"Sjalander","year":"2007","journal-title":"J Thromb Thrombolysis"},{"key":"R3-20230911","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/0002-9378(90)90031-2","article-title":"Measured menstrual blood loss in women with a bleeding disorder or using oral anticoagulant therapy","volume":"162","author":"van Eijkeren","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"R4-20230911","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"key":"R5-20230911","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3109\/00016346609158455","article-title":"Menstrual blood loss\u2014a population study. Variation at different ages and attempts to define normality","volume":"45","author":"Hallberg","year":"1966","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R6-20230911","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.ajog.2003.11.015","article-title":"Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data","volume":"190","author":"Warner","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20230911","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"R8-20230911","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1182\/blood-2017-07-797423","article-title":"How I treat heavy menstrual bleeding associated with anticoagulants","volume":"130","author":"Boonyawat","year":"2017","journal-title":"Blood"},{"key":"R9-20230911","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1160\/TH16-11-0874","article-title":"Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin","volume":"117","author":"Brekelmans","year":"2017","journal-title":"Thromb Haemost"},{"key":"R10-20230911","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1182\/blood.V128.22.140.140","article-title":"Dabigatran is associated with a significantly lower risk of abnormal uterine bleeding than warfarin in female patients of childbearing age with venous thromboembolism","volume":"128","author":"Ferreira","year":"2016","journal-title":"Blood"},{"key":"R11-20230911","doi-asserted-by":"crossref","first-page":"43","DOI":"10.7812\/TPP\/13-018","article-title":"Acute uterine bleeding unrelated to pregnancy: a Southern California Permanente Medical Group practice guideline","volume":"17","author":"Munro","year":"2013","journal-title":"Perm J"},{"key":"R12-20230911","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/AOG.0b013e3181cb50b5","article-title":"ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives","volume":"115","author":"Reid","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R13-20230911","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/AOG.0b013e3182839e0e","article-title":"Nonsurgical management of heavy menstrual bleeding: a systematic review","volume":"121","author":"Matteson","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R14-20230911","first-page":"CD004695","article-title":"Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception","volume":"7","author":"Edelman","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R15-20230911","first-page":"CD003989","article-title":"20 microg versus >20 microg estrogen combined oral contraceptives for contraception","volume":"8","author":"Gallo","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R16-20230911","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/01.AOG.0000199950.64545.16","article-title":"Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?","volume":"107","author":"Edelman","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R17-20230911","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijgo.2015.10.028","article-title":"Rationale for eliminating the hormone-free interval in modern oral contraceptives","volume":"134","author":"London","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"R18-20230911","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.contraception.2009.02.008","article-title":"Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons","volume":"80","author":"Hubacher","year":"2009","journal-title":"Contraception"},{"key":"R19-20230911","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.contraception.2009.02.007","article-title":"The effect of levonorgestrel-releasing intrauterine device on menorrhagia in women taking anticoagulant medication after cardiac valve replacement","volume":"80","author":"Kilic","year":"2009","journal-title":"Contraception"},{"key":"R20-20230911","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2004.06.011","article-title":"Contraceptive efficacy and safety of DMPA-SC","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"key":"R21-20230911","first-page":"CD001016","article-title":"Cyclical progestogens for heavy menstrual bleeding","volume":"23","author":"Lethaby","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"R22-20230911","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"R23-20230911","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1136\/bmj.e2990","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10","volume":"344","author":"Lidegaard","year":"2012","journal-title":"BMJ"},{"key":"R24-20230911","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"R25-20230911","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/AOG.0000000000000411","article-title":"Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes","volume":"124","author":"Bergendal","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R26-20230911","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device","volume":"30","author":"van Hylckama Vlieg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R27-20230911","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"R28-20230911","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"key":"R29-20230911","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)04394-9","article-title":"Risk of idiopathic venous thromboembolism in users of progestagens alone","volume":"354","author":"Vasilakis","year":"1999","journal-title":"Lancet"},{"key":"R31-20230911","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jpag.2014.12.012","article-title":"Oral tranexamic acid versus combined oral contraceptives for adolescent heavy menstrual bleeding: a pilot study","volume":"28","author":"Srivaths","year":"2015","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R32-20230911","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1600-0412.2012.01361.x","article-title":"Efficacy of tranexamic acid in the treatment of idiopathic and non-functional heavy menstrual bleeding: a systematic review","volume":"91","author":"Naoulou","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R33-20230911","first-page":"CD000329","article-title":"Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding","volume":"11","author":"Fergusson","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R34-20230911","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta15190","article-title":"Hysterectomy, endometrial ablation and Mirena for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis","volume":"15","author":"Bhattacharya","year":"2011","journal-title":"Health Technol Assess"},{"key":"R35-20230911","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1471-0528.2004.00158.x","article-title":"Evaluation of the effect of uterine artery embolisation on menstrual blood loss and uterine volume","volume":"111","author":"Khaund","year":"2004","journal-title":"BJOG"},{"key":"R36-20230911","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1046\/j.1471-0528.2002.01449.x","article-title":"Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow up","volume":"109","author":"Walker","year":"2002","journal-title":"BJOG"},{"key":"R37-20230911","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/jama.291.12.1447","article-title":"Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial","volume":"291","author":"Kuppermann","year":"2004","journal-title":"JAMA"},{"key":"R38-20230911","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1055\/s-0031-1287662","article-title":"The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding","volume":"29","author":"Fraser","year":"2011","journal-title":"Semin Reprod Med"},{"key":"R39-20230911","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejogrb.2011.04.025","article-title":"Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel","volume":"158","author":"James","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R40-20230911","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0002-9378(83)90237-5","article-title":"Uterine tamponade for the control of acute uterine bleeding","volume":"147","author":"Goldrath","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"R41-20230911","doi-asserted-by":"crossref","first-page":"2769.e13","DOI":"10.1016\/j.fertnstert.2010.04.058","article-title":"Intrauterine balloon tamponade as a treatment for immune thrombocytopenic purpura-induced severe uterine bleeding","volume":"94","author":"Hamani","year":"2010","journal-title":"Fertil Steril"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003081-201806000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T08:13:04Z","timestamp":1694419984000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201806000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000372","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}